Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
The National Institute of Health (NIH) posted What’s New in the Guidelines on May 31, 2022. Major revisions in May include:
- Critical Care for Children
- Antithrombotic Therapy in Patients with COVID-19
- Critical Care for Adults
- Corticosteroids
- Colchicine
- Special Considerations in Adults and Children with Cancer
- Special Considerations in Solid Organ Transplant, Hematopoietic Stem Cell Transplant and Cellular Immunotherapy Candidates, Donors and Recipients
- Ritonavir-Boosted Nirmatrelvir (Paxlovid)
- Drug-Drug Interactions between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications
- Prioritization of Anti-SARS-CoV-2 Therapies for the Treatment and Prevention of COVID-19 When There Are Logistical or Supply Constraints
The Full Guidelines, downloaded from https://www.covid19treatmentguidelines.nih.gov on June 1, 2022, are found here.